| Authors | Christoph Driessen, Rouven Müller, Urban Novak, Nathan Cantoni, Daniel Betticher, Nicolas Mach, Axel Rüfer, Ulrich Mey, Panagiotis Samaras, Karin Ribi, Lenka Besse, Andrej Besse, Catherine Berset, Stephanie Rondeau, Hanne Hawle, Felicitas Hitz, Thomas Pabst, Thilo Zander |
| Journal | Blood
(Blood)
Vol. 132
Issue 19
Pg. 2097-2100
(11 08 2018)
ISSN: 1528-0020 [Electronic] United States |
| PMID | 30237154
(Publication Type: Clinical Trial, Phase II, Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
|
| Chemical References |
- Antineoplastic Agents
- HIV Protease Inhibitors
- Proteasome Inhibitors
- Bortezomib
- Dexamethasone
- Nelfinavir
|
| Topics |
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents
(therapeutic use)
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Bortezomib
(therapeutic use)
- Dexamethasone
(therapeutic use)
- Female
- HIV Protease Inhibitors
(therapeutic use)
- Humans
- Male
- Middle Aged
- Multiple Myeloma
(drug therapy)
- Nelfinavir
(therapeutic use)
- Proteasome Inhibitors
(therapeutic use)
- Treatment Outcome
|
